# Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors

> **NCT01137162** · — · TERMINATED · sponsor: **Stanford University** · enrollment: 10 (actual)

## Conditions studied

- Anal, Colon, and Rectal Cancers
- Head and Neck Cancer
- Lung Cancer
- Colon Cancer
- Colonic Neoplasms
- Colorectal Neoplasms
- Colon/Rectal Cancer
- Colon/Rectal Cancer Colon Cancer
- Colon/Rectal Cancer Rectal Cancer
- Colon/Rectal Cancer Anal Cancer
- Head and Neck Cancers
- Head and Neck Cancers Lip
- Head and Neck Cancers Oral Cavity
- Head and Neck Cancers Nasopharynx
- Head and Neck Cancers Oropharynx
- Head and Neck Cancers Hypopharynx
- Head and Neck Cancers Larynx
- Head and Neck Cancers Trachea
- Lung Cancer Non-Small Cell Cancer (NSCLC)
- Lung Cancer Small Cell Lung Cancer (SCLC)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01137162
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2008-08
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Low Accrual
- **Last updated:** 2016-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01137162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01137162, "Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01137162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*